Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

October 31, 2008

Study Completion Date

December 31, 2008

Conditions
Acute Lymphoblastic Leukemia
Interventions
PROCEDURE

Collection of treatment-stratefying prognostic factors

Trial Locations (1)

31059

Service d'Hématologie Clinique, Hôpital Purpan, Toulouse

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

lead

University Hospital, Toulouse

OTHER

NCT00222027 - Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial | Biotech Hunter | Biotech Hunter